GlassScriptPhysician profile
Veronica A Lee
NPI 1851918718
$2,388.73
in general payments reported to CMS, 2019-2025
23 companies · $1,258 in 2025
The $1,258 reported for 2025 was more than what 90% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $17.91 · 2021: $115 · 2022: $12.22 · 2023: $298 · 2024: $687 · 2025: $1,258.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,244.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,243.68 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $747.14 | 2023-2025 | Airsupra, Farxiga, Breztri |
| Abbvie INC. | $350.10 | 2021-2025 | |
| Lilly USA, LLC | $198.87 | 2021-2025 | Jardiance, Mounjaro, Zepbound |
| Novo Nordisk INC | $136.56 | 2023-2025 | Wegovy, Ozempic, Rybelsus |
| Boehringer Ingelheim Pharmaceuticals, INC. | $133.08 | 2023-2025 | Tradjenta, Jardiance |
| Glaxosmithkline, LLC. | $122.68 | 2024-2025 | Shingrix, Arexvy, Trelegy Ellipta |
| Dexcom, INC. | $112.52 | 2024-2025 | Dexcom G6 Transmitter |
| Pfizer INC. | $109.65 | 2024-2025 | |
| Kowa Pharmaceuticals America, INC. | $69.05 | 2025 | Zoryve |
| Intra-Sana Laboratories | $50.00 | 2025 | Reltone 400 Mg, Glycate, Reltone 200 Mg |
| Gilead Sciences, INC. | $48.81 | 2024-2025 | |
| Boston Scientific Corporation | $47.77 | 2025 | Wavewriter Alpha Prime 16 |
| Esperion Therapeutics, INC. | $45.81 | 2020-2024 | Nexletol |
| Bayer Healthcare Pharmaceuticals INC. | $33.97 | 2025 | |
| Merck Sharp & Dohme LLC | $26.80 | 2022-2025 | M-M-R II, Capvaxive, Rotateq |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ascensia Diabetes Care US INC. | $24.31 | 2025 | |
| Teleflex LLC | $23.92 | 2025 | Barrigel |
| Hologic Sales and Service, LLC | $22.74 | 2025 | Aptima |
| Exact Sciences Corporation | $22.70 | 2023 | Cologuard Collection Kit |
| Xeris Pharmaceuticals, INC. | $21.84 | 2025 | Recorlev |
| Janssen Pharmaceuticals, INC | $16.14 | 2023 | Xarelto |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $13.11 | 2021 | |
| Eisai INC. | $11.16 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Veronica Lee listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.